Singular Genomics Systems, Inc.

NasdaqCM:OMIC Stock Report

Market Cap: US$50.4m

Singular Genomics Systems Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Drew Spaventa

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage34.8%
CEO tenure9yrs
CEO ownership5.7%
Management average tenure3.8yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Singular Genomics cut to Neutral at UBS on delays for sequencer shipments

Aug 17

Singular Genomics Systems GAAP EPS of -$0.34

Aug 09

CEO Compensation Analysis

How has Drew Spaventa's remuneration changed compared to Singular Genomics Systems's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$86m

Jun 30 2024n/an/a

-US$92m

Mar 31 2024n/an/a

-US$96m

Dec 31 2023US$2mUS$546k

-US$95m

Sep 30 2023n/an/a

-US$93m

Jun 30 2023n/an/a

-US$94m

Mar 31 2023n/an/a

-US$93m

Dec 31 2022US$5mUS$521k

-US$91m

Sep 30 2022n/an/a

-US$90m

Jun 30 2022n/an/a

-US$83m

Mar 31 2022n/an/a

-US$97m

Dec 31 2021US$678kUS$431k

-US$99m

Sep 30 2021n/an/a

-US$87m

Jun 30 2021n/an/a

-US$77m

Mar 31 2021n/an/a

-US$47m

Dec 31 2020US$475kUS$366k

-US$28m

Compensation vs Market: Drew's total compensation ($USD1.57M) is above average for companies of similar size in the US market ($USD643.82K).

Compensation vs Earnings: Drew's compensation has been consistent with company performance over the past year.

CEO

Drew Spaventa (38 yo)

9yrs

Tenure

US$1,567,091

Compensation

Mr. Andrew Spaventa, also known as Drew, founded Singular Genomics Systems, Inc. in 2016 and has been its Director since 2016. Mr. Spaventa serves as the Chairman and Chief Executive Officer of Singular Ge...

Leadership Team

NamePositionTenureCompensationOwnership
Andrew Spaventa
Founder9yrsUS$1.57m5.66%
$ 2.9m
David Barker
Founderno dataUS$113.61k1.41%
$ 708.9k
Eli Glezer
Founder9yrsUS$915.28k6.17%
$ 3.1m
Dalen Meeter
Chief Financial Officer5.1yrsUS$851.48k0.36%
$ 180.6k
Jyotsna Ghai
Chief Operating Officer2yrsno data0.12%
$ 60.9k
Eric Stier
Senior VP1.6yrsno datano data
Jeff Bullard
Head of Sales2.4yrsno datano data
Vincent Brancaccio
Head of Human Resources5.3yrsno datano data
Jorge Velarde
Chief Business Officerless than a yearno datano data

3.8yrs

Average Tenure

51yo

Average Age

Experienced Management: OMIC's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Spaventa
Founder9yrsUS$1.57m5.66%
$ 2.9m
David Barker
Founder8.3yrsUS$113.61k1.41%
$ 708.9k
Eli Glezer
Founderno dataUS$915.28k6.17%
$ 3.1m
Elaine Mardis
Member of Scientific Advisory Board & Independent Director3yrsUS$98.61k0%
$ 0
Michael Pellini
Independent Lead Director7.8yrsUS$131.50k0.47%
$ 234.9k
Kim Kamdar
Independent Director7.7yrsUS$103.61k0.020%
$ 10.0k
David Ledbetter
Member of Scientific Advisory Board2.7yrsno datano data
Jason Ryan
Independent Director3.8yrsUS$113.61k0%
$ 0
Marcia Eisenberg
Independent Director1.4yrsUS$87.05kno data
Lawrence Fong
Member of Scientific Advisory Board2.7yrsno datano data

3.8yrs

Average Tenure

57.5yo

Average Age

Experienced Board: OMIC's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 06:36
End of Day Share Price 2025/01/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Singular Genomics Systems, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael RyskinBofA Global Research
null nullEquisights
Matthew SykesGoldman Sachs